Predicting prostate cancer in older men
Part of Cancer, Kidney & urinary clinical trials.
This study looks at how well a standard prostate biopsy can find cancer in men aged 70 or older. It aims to help doctors decide which older men need a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years old or older.
- You have a high PSA level of 20 or above.
- You have signs that might be prostate cancer, such as a high PSA or a lump felt during a rectal exam.
- You are healthy enough that your doctor expects you to live at least 10 more years.
- You have not been diagnosed with prostate cancer before.
- You have not had a prostate MRI, a rectal exam, or ejaculated within the last 2 days (or 2 years for MRI).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced imaging scans (MRI and ultrasound) and lab analysis of tissue samples to better predict prostate cancer. If you've had or are planning a prostate biopsy or surgery, your imaging and tissue results could help doctors develop better tools to diagnose prostate cancer.
This study uses a simple blood test to look for microRNA patterns that may help spot prostate cancer earlier and avoid unnecessary biopsies. If you have elevated PSA or suspicious findings, this test might give more information about your risk.
This study uses a new artificial intelligence test to look for tiny amounts of cancer DNA in your blood. It aims to help catch prostate cancer earlier, when it may be easier to treat.
This study tests a new computer program that reads MRI scans to help doctors decide if a prostate biopsy is truly needed. It aims to reduce unnecessary biopsies for men with suspicious test results.
This study tests a new biopsy system that uses MRI images and metabolic information to guide doctors to the most suspicious areas of the prostate during the biopsy. This could make the biopsy more accurate and help diagnose prostate cancer better.
This study uses a blood test to detect prostate cancer more accurately than traditional methods. It looks for genetic material from cancer cells to help decide if a prostate biopsy is needed.
Hear when a new Prostate Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.